Cleared Traditional

K910680 - EPINEPHRINE REAGENT, CAT. NO. 5367

K910680 is an FDA 510(k) clearance for EPINEPHRINE REAGENT, manufactured by Helena Laboratories. The device is a Class 2 Hematology device with product code GHR cleared through the Traditional 510(k) pathway after a 94-day FDA review.

K910680 · Helena Laboratories · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1991
Decision
94d
Days
Class 2
Risk

K910680 is an FDA 510(k) clearance for the EPINEPHRINE REAGENT, CAT. NO. 5367. Classified as Reagent, Platelet Aggregation (product code GHR), Class II - Special Controls.

Submitted by Helena Laboratories (Beaumont, US). The FDA issued a Cleared decision on May 20, 1991 after a review of 94 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5700 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Helena Laboratories devices

FDA 510(k) Submission Details - K910680

510(k) Number K910680 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 15, 1991
Decision Date May 20, 1991
Days to Decision 94 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
19d faster than avg
Panel avg: 113d · This submission: 94d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GHR Device Classification - Class 2, Special Controls

Product Code GHR Reagent, Platelet Aggregation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GHR Reagent, Platelet Aggregation

All 7
Devices cleared under the same product code (GHR) and FDA review panel - the closest regulatory comparables to K910680.
PLATELETWORKS ARACHIDONIC ACID, MODEL PW-ACA
K061991 · Helena Laboratories · Feb 2007
ADP REAGENT, MODIFIED
K952252 · Helena Laboratories · Sep 1995
COLLAGEN REAGENT CAT. NO. 5368
K910706 · Helena Laboratories · May 1991
ADP REAGENT
K910800 · Helena Laboratories · May 1991
PLATELET AGGREGATION REAGENTS
K910286 · Medical Diagnostic Technologies, Inc. · Mar 1991
RISTOCETIN
K900792 · Medical Diagnostic Technologies, Inc. · Mar 1990